2-Bromo-1-(5-chloropyridin-2-yl)ethanone → Methyl[5-chloro-2-(5-chloropyridine-2-carbonyl)-1h-indol-3-yl]acetate
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([NH:14]S(C2C=CC=CC=2)(=O)=O)=[C:6]([CH:13]=1)/[CH:7]=[CH:8]/[C:9]([O:11][CH3:12])=[O:10].Br[CH2:25][C:26]([C:28]1[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][N:29]=1)=[O:27]>>[CH3:12][O:11][C:9](=[O:10])[CH2:8][C:7]1[C:6]2[C:5](=[CH:4][CH:3]=[C:2]([Cl:1])[CH:13]=2)[NH:14][C:25]=1[C:26]([C:28]1[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][N:29]=1)=[O:27]Participants
3
Procedure
The title compound was prepared according to the procedure described in Example 57 from methyl trans-5-chloro-2-(phenylsulfonylamino)cinnamate (Example 36, step 3) and 2-bromoacetyl-5-chloropyridine*.
Sources & evidence
- ORD record
- ord-2eda7e33aebd4a31b3dcf149fc4bd1e7
- Source dataset
- uspto-grants-2003_08
- Patent number
- US06608070B1
Reaction notes
Loading…